Insulet (PODD) Non-Current Debt (2010 - 2026)
Insulet's (PODD) quarterly Non-Current Debt came in at $929.5 million in Q2 2026, down 1.01% on a YoY basis from $939.0 million in Q2 2025, and little changed quarter-over-quarter from $929.5 million in Q1 2026.
Analysis
Insulet (PODD) Non-Current Debt (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Non-Current Debt for 17 consecutive years, with $929.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Debt fell 1.01% year-over-year to $929.5 million; the trailing twelve-month figure through Jun 2026 stood at $929.5 million (down 1.01% YoY), and the FY2025 full-year result was $930.8 million, down 28.18% from the prior year.
- Non-Current Debt was little changed at $929.5 million in Q2 2026 per PODD's latest filing, from $929.5 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.6 billion in Q1 2025 and bottomed at $929.5 million in Q1 2026.
- Historically, Non-Current Debt has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2023.
- The sharpest annual moves came in 2022 and 2026: Non-Current Debt soared 32.69% in 2022, then slumped 42.35% in 2026.
- Over 5 years, Non-Current Debt stood at $1.4 billion in 2022, then slipped by 0.57% to $1.4 billion in 2023, then dropped by 5.14% to $1.3 billion in 2024, then declined by 28.18% to $930.8 million in 2025, then retreated by 0.14% to $929.5 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $929.5 million, $929.5 million, and $930.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 929.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 929.50 Mn |
| Mar 31, 2026 | 929.50 Mn |
| Dec 31, 2025 | 930.80 Mn |
| Sep 30, 2025 | 934.90 Mn |
| Jun 30, 2025 | 939.00 Mn |
| Mar 31, 2025 | 1.61 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 1.36 Bn |
| Jun 30, 2024 | 1.36 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.37 Bn |
| Sep 30, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.40 Bn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 1.41 Bn |
| Jun 30, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.42 Bn |
| Dec 31, 2021 | 1.27 Bn |
| Sep 30, 2021 | 1.29 Bn |